152 related articles for article (PubMed ID: 25862954)
1. Functional interaction between CTGF and FPRL1 regulates VEGF-A-induced angiogenesis.
Lee MS; Ghim J; Kim SJ; Yun YS; Yoo SA; Suh PG; Kim WU; Ryu SH
Cell Signal; 2015 Jul; 27(7):1439-48. PubMed ID: 25862954
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
[TBL] [Abstract][Full Text] [Related]
3. Nelumbo nucifera Gaertn leaves extract inhibits the angiogenesis and metastasis of breast cancer cells by downregulation connective tissue growth factor (CTGF) mediated PI3K/AKT/ERK signaling.
Chang CH; Ou TT; Yang MY; Huang CC; Wang CJ
J Ethnopharmacol; 2016 Jul; 188():111-22. PubMed ID: 27178635
[TBL] [Abstract][Full Text] [Related]
4. Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells.
Coffelt SB; Tomchuck SL; Zwezdaryk KJ; Danka ES; Scandurro AB
Mol Cancer Res; 2009 Jun; 7(6):907-15. PubMed ID: 19491199
[TBL] [Abstract][Full Text] [Related]
5. Pituitary adenylate cyclase-activating polypeptide 27 is a functional ligand for formyl peptide receptor-like 1.
Kim Y; Lee BD; Kim O; Bae YS; Lee T; Suh PG; Ryu SH
J Immunol; 2006 Mar; 176(5):2969-75. PubMed ID: 16493055
[TBL] [Abstract][Full Text] [Related]
6. The formyl peptide receptor like-1 and scavenger receptor MARCO are involved in glial cell activation in bacterial meningitis.
Braun BJ; Slowik A; Leib SL; Lucius R; Varoga D; Wruck CJ; Jansen S; Podschun R; Pufe T; Brandenburg LO
J Neuroinflammation; 2011 Feb; 8(1):11. PubMed ID: 21299846
[TBL] [Abstract][Full Text] [Related]
7. NADPH-oxidase-dependent reactive oxygen species mediate EGFR transactivation by FPRL1 in WKYMVm-stimulated human lung cancer cells.
Cattaneo F; Iaccio A; Guerra G; Montagnani S; Ammendola R
Free Radic Biol Med; 2011 Sep; 51(6):1126-36. PubMed ID: 21708247
[TBL] [Abstract][Full Text] [Related]
8. Functional and physical interactions between formyl-peptide-receptors and scavenger receptor MARCO and their involvement in amyloid beta 1-42-induced signal transduction in glial cells.
Brandenburg LO; Konrad M; Wruck CJ; Koch T; Lucius R; Pufe T
J Neurochem; 2010 May; 113(3):749-60. PubMed ID: 20141570
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Phospholipase D 1 and 2 in the subcellular localization and activity of formyl-peptide-receptors in the human colonic cell line HT29.
Brandenburg LO; Seyferth S; Wruck CJ; Koch T; Rosenstiel P; Lucius R; Pufe T
Mol Membr Biol; 2009 Aug; 26(5):371-83. PubMed ID: 19707939
[TBL] [Abstract][Full Text] [Related]
10. Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
Inoki I; Shiomi T; Hashimoto G; Enomoto H; Nakamura H; Makino K; Ikeda E; Takata S; Kobayashi K; Okada Y
FASEB J; 2002 Feb; 16(2):219-21. PubMed ID: 11744618
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.
Lin MT; Yen ML; Lin CY; Kuo ML
Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751
[TBL] [Abstract][Full Text] [Related]
12. CTGF increases vascular endothelial growth factor-dependent angiogenesis in human synovial fibroblasts by increasing miR-210 expression.
Liu SC; Chuang SM; Hsu CJ; Tsai CH; Wang SW; Tang CH
Cell Death Dis; 2014 Oct; 5(10):e1485. PubMed ID: 25341039
[TBL] [Abstract][Full Text] [Related]
13. The peptide Trp-Lys-Tyr-Met-Val-D-Met activates neutrophils through the formyl peptide receptor only when signaling through the formylpeptide receptor like 1 is blocked. A receptor switch with implications for signal transduction studies with inhibitors and receptor antagonists.
Karlsson J; Fu H; Boulay F; Bylund J; Dahlgren C
Biochem Pharmacol; 2006 May; 71(10):1488-96. PubMed ID: 16549058
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone inhibits vascular endothelial growth factor-induced angiogenic signaling via suppression of reactive oxygen species production and extracellular signal-regulated kinase phosphorylation in endothelial cells.
Park BC; Thapa D; Lee JS; Park SY; Kim JA
J Pharmacol Sci; 2009 Sep; 111(1):1-12. PubMed ID: 19763043
[TBL] [Abstract][Full Text] [Related]
15. Lipoxin A4 inhibits proliferation of human lung fibroblasts induced by connective tissue growth factor.
Wu SH; Wu XH; Lu C; Dong L; Chen ZQ
Am J Respir Cell Mol Biol; 2006 Jan; 34(1):65-72. PubMed ID: 16141446
[TBL] [Abstract][Full Text] [Related]
16. Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1.
Björkman L; Karlsson J; Karlsson A; Rabiet MJ; Boulay F; Fu H; Bylund J; Dahlgren C
J Leukoc Biol; 2008 Feb; 83(2):245-53. PubMed ID: 17984291
[TBL] [Abstract][Full Text] [Related]
17. Human cathelicidin antimicrobial peptide LL-37 promotes lymphangiogenesis in lymphatic endothelial cells through the ERK and Akt signaling pathways.
Yanagisawa T; Ishii M; Takahashi M; Fujishima K; Nishimura M
Mol Biol Rep; 2020 Sep; 47(9):6841-6854. PubMed ID: 32886325
[TBL] [Abstract][Full Text] [Related]
18. FPRL1-mediated induction of superoxide in LL-37-stimulated IMR90 human fibroblast.
Iaccio A; Cattaneo F; Mauro M; Ammendola R
Arch Biochem Biophys; 2009 Jan; 481(1):94-100. PubMed ID: 18996352
[TBL] [Abstract][Full Text] [Related]
19. Differential activation of formyl peptide receptor-like 1 by peptide ligands.
Bae YS; Yi HJ; Lee HY; Jo EJ; Kim JI; Lee TG; Ye RD; Kwak JY; Ryu SH
J Immunol; 2003 Dec; 171(12):6807-13. PubMed ID: 14662886
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
